Anticancer genes (NOXA, PAR-4, TRAIL) are de-regulated in breast cancer patients and can be targeted by using a ribosomal inactivating plant protein (riproximin).

MLA

Pervaiz, Asim, et al. “Anticancer Genes (NOXA, PAR-4, TRAIL) Are de-Regulated in Breast Cancer Patients and Can Be Targeted by Using a Ribosomal Inactivating Plant Protein (Riproximin).” Molecular Biology Reports, vol. 50, no. 6, June 2023, pp. 5209–21. EBSCOhost, https://doi.org/10.1007/s11033-023-08477-3.

APA

Pervaiz, A., Naseem, N., Saleem, T., Raza, S. M., Shaukat, I., Kanwal, K., Sajjad, O., Iqbal, S., Shams, F., Ijaz, B., & Berger, M. R. (2023). Anticancer genes (NOXA, PAR-4, TRAIL) are de-regulated in breast cancer patients and can be targeted by using a ribosomal inactivating plant protein (riproximin). Molecular Biology Reports, 50(6), 5209–5221. https://doi.org/10.1007/s11033-023-08477-3

Chicago

Pervaiz, Asim, Nadia Naseem, Talha Saleem, Syed Mohsin Raza, Iqra Shaukat, Kinzah Kanwal, Osheen Sajjad, et al. 2023. “Anticancer Genes (NOXA, PAR-4, TRAIL) Are de-Regulated in Breast Cancer Patients and Can Be Targeted by Using a Ribosomal Inactivating Plant Protein (Riproximin).” Molecular Biology Reports 50 (6): 5209–21. doi:10.1007/s11033-023-08477-3.